You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Extraskeletal myxoid chondrosarcoma

Showing 1 - 25 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma Trial in Spain (Pazopanib)

Active, not recruiting
  • Solitary Fibrous Tumor
  • Extraskeletal Myxoid Chondrosarcoma
  • Palma De Mallorca, Islas Baleares, Spain
  • +6 more
Jan 31, 2022

Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)

Enrolling by invitation
  • Ewing Sarcoma
  • +8 more
  • Santa Monica, California
    Sarcoma Oncology Center
Feb 23, 2022

Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

Not yet recruiting
  • Metastatic Extraskeletal Myxoid Chondrosarcoma
  • +3 more
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)

Recruiting
  • Ewing Sarcoma
  • +10 more
  • Los Angeles, California
  • +16 more
Jan 18, 2022

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Conventional Chondrosarcoma, Myxoid Liposarcoma, Mesenchymal Chondrosarcoma Trial in Netherlands, Spain (sirolimus and

Completed
  • Conventional Chondrosarcoma
  • +3 more
  • sirolimus and cyclophosphamide
  • Leiden, Netherlands
  • +6 more
Apr 19, 2022

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting
  • Metastatic Leiomyosarcoma
  • +17 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 13, 2022

Osteosarcoma, Bone Tumor, Bone Sarcoma Trial

Not yet recruiting
  • Osteosarcoma
  • +25 more
    • (no location specified)
    Aug 24, 2022

    Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

    Temporarily not available
    • Epithelioid Sarcoma (Ex-US Only)
    • +19 more
    • (no location specified)
    Oct 17, 2022

    Mesenchymal Chondrosarcoma Trial in Italy (Trabectedin)

    Active, not recruiting
    • Mesenchymal Chondrosarcoma
    • Prato, Firenze, Italy
    • +5 more
    Oct 29, 2021

    Sarcoma Trial in Worldwide (RG1507)

    Terminated
    Has Results
    • Sarcoma
    • Duarte, California
    • +40 more
    Jan 14, 2021

    Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab

    Recruiting
    • Soft Tissue Sarcoma
    • Bone Sarcoma
    • Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
    • +7 more
    • Bologna, Italy
    • +12 more
    Nov 10, 2021

    Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma Trial in Worldwide (Tazemetostat)

    Completed
    • Rhabdoid Tumors
    • +3 more
    • Los Angeles, California
    • +34 more
    Dec 23, 2021

    Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

    Active, not recruiting
    • Malignant Rhabdoid Tumors (MRT)
    • +10 more
    • San Francisco, California
    • +31 more
    Jan 17, 2023

    Tumors Trial in United States (letetresgene autoleucel (GSK3377794), Cyclophosphamide, Fludarabine)

    Completed
    Has Results
    • Neoplasms
    • letetresgene autoleucel (GSK3377794)
    • +2 more
    • Tampa, Florida
    • +5 more
    Oct 31, 2022

    Soft-tissue Sarcoma, Gastrointestinal Stromal Tumors, Bone Sarcoma Trial in Worldwide (Quality assessment)

    Unknown status
    • Soft-tissue Sarcoma
    • +2 more
    • Quality assessment
    • Buenos Aires, Argentina
    • +8 more
    Feb 9, 2021

    Engagement Trends in Chondrosarcoma Clinical Trials

    Not yet recruiting
    • Chondrosarcoma
      • San Francisco, California
        Power Life Sciences
      Sep 1, 2023

      Locally Advanced Unresectable Primary Central Chondrosarcoma, Metastatic Primary Central Chondrosarcoma, Unresectable Primary

      Suspended
      • Locally Advanced Unresectable Primary Central Chondrosarcoma
      • +2 more
      • Phoenix, Arizona
      • +38 more
      Feb 2, 2023

      Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1

      Not yet recruiting
      • Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
      • Ivosidenib 500mg
      • Placebo
      • (no location specified)
      Nov 7, 2023

      Periosteal Chondrosarcoma: a Single Institution Experience

      Completed
      • Periosteal Chondrosarcoma
        • Bologna, Italy
          IRCCS- Istituto Ortopedico Rizzoli
        Aug 22, 2022

        Chondrosarcoma Trial (Anlotinib HCl, PD-1 inhibitor)

        Not yet recruiting
        • Chondrosarcoma
        • Anlotinib hydrochloride
        • PD-1 inhibitor
        • (no location specified)
        Dec 31, 2021

        Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

        Terminated
        • Neoplasms
        • New Haven, Connecticut
        • +20 more
        Jul 5, 2023

        Chondrosarcoma Trial in Houston (Proton Beam Therapy)

        Active, not recruiting
        • Chondrosarcoma
        • Proton Beam Therapy
        • Houston, Texas
          MD Anderson Cancer Center
        Aug 25, 2022

        Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

        Terminated
        • Neoplasms
        • New Haven, Connecticut
        • +20 more
        Sep 15, 2023

        Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

        Available
        • Glioblastoma
        • +13 more
        • (no location specified)
        Jul 26, 2023